Venus Remedies Standalone September 2018 Net Sales at Rs 80.89 crore, down 10.63% Y-o-Y
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live VENUSREM message board: Is VENUSREM buy or sell? Should I buy VENUSREM shares? Why are VENUSREM shares falling? Should I invest in VENUSREM stock?
forum
VENUSREM Share Price Discussion
Venus Remedies Ltd.
NSE: VENUSREM | BSE: 526953 | ISIN: INE411B01019 | Sector: Pharmaceuticals and health care
Recent posts in VENUSREM
N
Reputation: 4,841 • Jul 29 3:51 AM
Share market update: 40 stocks hit 52-week highs on NSE
Overall, 32 shares were trading in green in Nifty50 index, while 18 were trading in red.
Overall, 32 shares were trading in green in Nifty50 index, while 18 were trading in red.
The Economic Times
Like
Reply
N
Reputation: 4,841 • Oct 16, 2019 2:03 AM
FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
SK Growth Fund acquired 2,45,459 shares of newly listed Vishwaraj Sugar Industries at Rs 60.35 per share.
SK Growth Fund acquired 2,45,459 shares of newly listed Vishwaraj Sugar Industries at Rs 60.35 per share.
Moneycontrol
Like
Reply
N
Reputation: 4,841 • Feb 18, 2019 4:57 AM
Venus Remedies Standalone December 2018 Net Sales at Rs 69.06 crore, down 25.84% Y-o-Y
Like
Reply
N
Reputation: 4,841 • Nov 16, 2018 4:17 AM
Venus Remedies soars after positive clinical trial results for flagship product
Like
Reply